Welcome to Estelle ICARD
✨ Welcome to Estelle ICARD at ATESSIA! She will be working as a Regulatory & Pharmaceutical Affairs Consultant! The whole team welcomes her ✏️
Atessia Event – Exploitant Information System
Atessia in collaboration with CAPE-Expert & Lutessa proposed a webinar on the theme “Exploitant Information System”.
A session attended by more than 80 people! On the agenda:
- Cybersecurity, a challenge for the pharmaceutical industry
- ANSM inspections and discrepancies in terms of data integrity and others
SFSTP: How to choose your primary packaging?
Read the article “How to choose your primary packaging? “by the SFSTP commission with the participation of our advisor Isabelle Mouvault. The first part of this article, available in French and English, can be found in the STP Pharma Pratiques magazine n°1 of 2021.
Welcome to Hiba MASSOUDY
✨ Welcome to Hiba MASSOUDY at ATESSIA! She will be working as a Career Manager! The whole team welcomes her 🚀
Welcome to Stéphanie DURLIN
✨ Welcome to Stéphanie Durlin at ATESSIA! She will be working as a Regulatory & Pharmaceutical Affairs Advisor! The whole team welcomes her 🤝
Welcome to Amarylys! ✨
Welcome to Amarylys! Atessia’s sister company, this new partner is represented by Géraldine BAUDOT-VISSER, Vanessa Montagne and Capucine Miara! 🌱
Find more information on www.amarylys.com !
AFAR: Reform of the ATU/RTU access measures
While waiting for the publication of the application decrees for the reform of early and compassionate access, you can read the article on this subject in the AFAR gazette n°108.
✏️ The article was jointly written by Jeanne Ducorroy of ATESSIA, Life Science Advisors and Diane Bandon-Tourret & Letizia Nieddu of LexCase Société d’Avocats.
We would like to thank the Editorial Committee of the AFAR Association française des affaires réglementaires for this publication
FEFIS: Atessia in the 2020 membership register.
Find Atessia in the 2020 edition of the French Federation of Health Industries (FEFIS) members’ register! An interview with Géraldine Baudot-Visser is to be read! 👏